To summarize, a CD73-directed immunotherapy could drive a palette of resident non-immune cells as well as immune cells in the irradiated lung towards an inflammatory phenotype or signaling that might contribute to the development of radiation-pneumonitis, whilst attenuating chronic effects that promote progression towards radiation-induced lung fibrosis. Here, NT5E is linked to pulmonary fibrosis.